Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Beki Kan is active.

Publication


Featured researches published by Beki Kan.


Pituitary | 2003

G protein mutations in pituitary tumors: a study on Turkish patients.

Beki Kan; Christopher T. Esapa; Tammam Sipahi; Cevdet Nacar; Fahir Özer; Nur Sayhan; Mehmet Yasar Kaynar; Ali Cetin Sarioglu; Philip Edward Harris

Activating mutations of the G proteins, Gsα (gsp) and Gi2α (gip) have been reported in subsets of pituitary tumors. The objective of the study was to assess the frequency of gsp and gip mutations in pituitary tumors from Turkish patients and to investigate the possibility of mutations of protein kinase A catalytic subunit (PKAC) that activates the downstream effectors of adenylyl cyclase. PCR-amplified genomic DNA was analyzed for the presence of mutations in codons 201 and 227 of Gsα, codon 179 and 205 of Gi2α and codon 196 of PKAC, by single strand conformation polymorphism analysis, allele-specific oligonucleotide hybridization and DNA sequencing.Twenty-two patients from Turkey, 15 females and 7 males were investigated; 7 somatotroph adenomas, 7 clinically non-functioning tumors, 7 prolactinomas and 1 corticotroph adenoma. G protein mutations were identified in 6 of 22 (27.3%) pituitary tumors. Four tumors (3/7 somatotroph adenomas, 43%, 1/7 clinically non-functioning tumor) demonstrated gsp mutations at codon 201 arginine to cysteine and one recurrent somatotroph adenoma demonstrated a mutation of the Gi2α gene at codon 193 lysine to arginine. One tumor exhibited a C to T variation in the intervening sequence between codons 179 and 205 of the Gi2α gene. No mutations at codon 227 of Gsα, codons 179 and 205 of Gi2α and codon 196 of the PKAC gene were identified.


Clinical and Experimental Hypertension | 2011

The Role of G Protein β3 Subunit Polymorphisms C825T, C1429T, and G5177A in Turkish Subjects with Essential Hypertension

Hulya Cabadak; Oya Orun; Cevdet Nacar; Yüksel Doğan; Ozlem Guneysel; Ali Serdar Fak; Beki Kan

Hypertension is a multifactorial disorder that constitutes a major risk factor for the cardiovascular system. Heterotrimeric G-proteins, which couple receptors for diverse extracellular enzymes or ion channels, are correlated with disease mechanisms. Several studies have demonstrated an association between G protein polymorphisms and essential hypertension in some populations, although contradictive results also exist. In this study, we have investigated the potential role of the C825T, C1429T, and G5177A polymorphisms of the β3 subunit of G-proteins in essential hypertension in a group of Turkish subjects. Genomic DNA from 106 normotensive individuals (117.4 ± 13.1, 75.2 ± 10.5; systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels, respectively) and 101 hypertensive subjects (152.3 ± 18.0, 92.5 ± 11.6; SBP and DBP levels, respectively) were studied by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequencing methods for these polymorphisms. Allele frequencies of the polymorphisms were consistent with Hardy Weinberg equilibrium, except for the C825T polymorphism (χ2 = 7.8). The frequencies of the 825T and 1429T variants were higher in hypertensive subjects compared to those of controls. Differences between hypertensives and controls were not statistically significant, though difference was very close to significance for C825T (p = 0.056 and 0.099 for 825T and 1429T, respectively). T allele frequency in overall population showed significant association with hypertension for C825T (0.0134). The prevalence of the 5177A-variant was very low and all subjects carrying it were heterozygotes in both groups.


Autonomic and Autacoid Pharmacology | 2009

Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line

Hülya Cabadak; Esra Küçükibrahimoğlu; Banu Aydin; Beki Kan; M. Zafer Gören

1 In the present study we have investigated the expression of muscarinic receptors in K562 erythroleukaemic cells and the effects of muscarinic agonist and antagonists on extracellular citrulline levels in these cells, as a marker of nitric oxide (NO) generation. 2 Muscarinic acetylcholine receptors (M(1)-M(5)) play key roles in regulating many diverse physiological processes. Recent studies suggest that muscarinic receptors mediate some cellular events in haematopoietic cells. Multiple subtypes of muscarinic receptors are expressed in different human cells. NO, a free radical and a signaling molecule, is involved in the regulation of many physiological functions and derived from certain nitric oxide synthases (NOS), which are related to muscarinic receptors. 3 In this study, the presence of M(2), M(3) and M(4) subtypes in K562, an erythroleukaemic cell line, was demonstrated by using the reverse transcriptase-polymerase chain reaction. Moreover, the generation of NO induced by carbachol, a non-selective muscarinic agonist, was investigated by using high-performance liquid chromatography to measure changes in extracellular l-citrulline levels. 4 We found that carbachol enhanced l-citrulline production in K562 erythroleukaemic cells. The effect of carbachol on l-citrulline production was antagonized by atropine and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), while tropicamide had little effect. These results suggest that the muscarinic receptor M(3) subtype may mediate NO signaling in K562 erythroleukaemic cells.


Leukemia Research | 2013

The role of intracellular pathways in the proliferation of human K562 cells mediated by muscarinic receptors.

Banu Aydin; Beki Kan; Hülya Cabadak

Muscarinic acetylcholine receptors (mAChRs) are members of the superfamily of G protein coupled receptors (GPCRs). Muscarinic receptors are relatively abundant in the central nervous system and in the peripheral parasympathetic nervous system. Several studies have suggested that muscarinic receptors also mediate some cellular events in hematopoietic cells. K562 erythroleukemia cells contain muscarinic receptors M2, M3 and M4, and activation of muscarinic receptors changes cell proliferation. We examined the effects of several compounds on cell proliferation in K562 erythroleukemia cells. These included a muscarinic receptor agonist carbachol (CCh), a protein kinase inhibitor staurosporine; the phospholipase C inhibitor U73122, the MEK 1-2 inhibitor UO126, the PI3-kinase inhibitor wortmannin, the Ca(2+) chelators BAPTA/AM and 2-aminoethoxy-diphenylborate (2APB). In addition, we also investigated muscarinic receptor mediated protein kinase C (PKC) expression in K562 cells. CCh caused a decrease in DNA synthesis in K562 cells supplemented with 1% fetal bovine serum after starvation. Pre-treatment of K562 cells with U73122 and BAPTA/AM antagonized the inhibitory effect of CCh, suggesting that phospholipase C and intracellular calcium are involved in CCh-mediated inhibition of proliferation in K562 cells. Our data also suggest that the regulatory roles of protein kinase C and the MAPK/ERK pathways in K562 cell proliferation are independent of cholinergic activation.


Journal of Receptors and Signal Transduction | 2009

M2, M3, and M4 muscarinic receptors are expressed in the guinea pig gallbladder

Hülya Cabadak; Adolfo E. Cuadra; Esam E. El-Fakahany; Beki Kan

Aim: The identity of muscarinic acetylcholine receptors (mAchR) involved in cholinergic-mediated contraction of the guinea pig gallbladder has been a matter of debate. Different groups have suggested the involvement of M1, M2, M3, or M4 receptor subtypes in the contraction of this tissue. The objective of this study was to identify the mAchR subtypes expressed in the guinea pig gallbladder by RT-PCR. Methods: Total RNA prepared from frozen guinea pig gallbladder tissue was amplified by using specific primers for the M1–M4 receptor subtypes. Results: M2, M3, and M4 transcripts were detected in the following rank order: M4 > M2 > M3. We were unable to demonstrate the expression of the M1 receptor subtype in this tissue. Conclusions: Our results are in agreement with our previous binding and functional data.


Spectroscopy | 2011

Structural characterization of recombinant bovine Goα by spectroscopy and homology modeling

Pınar Mega Tiber; Oya Orun; Cevdet Nacar; Ugur Osman Sezerman; Feride Severcan; Mete Severcan; André Matagne; Beki Kan

Go, a member of heterotrimeric guanine nucleotide-binding proteins, is the most abundant form of G protein in the central and peripheral nervous systems. Goα has a significant role in neuronal development and function but its signal transduction mechanism remains to be clarified. In this study, the bovine Goα subunit was overexpressed and purified into homogeneity. Its activity was studied using ( 35 S) GTPγS binding, intrinsic fluorescence and BODIPY assays. The secondary structure was determined by both FTIR and CD spectroscopy as 42.3% α-helix, 13.4% β-sheet and 24.3% β-turn. A theoretical structure model was constructed. The structure from homology modeling is in very good agreement with the crystal structure of mouse Goα subunit except for the loop between αB-αC helices. This model was docked to the mouse RGS16 molecule. T117 on the αB-αC loop of Goα interacted with K172 on RGS16 as opposed to the T117 and K164 interaction in mouse.


Life Sciences | 2006

Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells

Bahire Küçükkaya; Devrim Oz Arslan; Beki Kan


Archive | 2011

Muscarinic receptor mediated cAMP response in human K562 chronic myelogenous leukemia cells

Hülya Cabadak; Banu Aydin; Beki Kan


Archive | 2013

Muscarinic agonist, antagonists and signaling pathway inhibitors change c-Fos and cyclin D 1 expression in K562 cells K562 hücrelerinde muskarinik agonist, antagonist ve sinyal ileti yolaği inhibitörleri c-Fos ve siklin D 1 ekspresyonlarini değiştirir

Hülya Cabadak; Banu Aydin; Beki Kan


Archive | 2012

GNAI2 Geninde İki Aday Polimorfizm

Emrah Kara; Cevdet Nacar; Beki Kan

Collaboration


Dive into the Beki Kan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge